Contract facts
FederalNo full NAICS 541620 intel page yet. Browse NAICS intelligence
TOX PROFILE - TOX 10: PERFLUOROALKYLS is a federal award for Cdc Office Of Acquisition Services held by Syracuse Research Corp. Estimated value $471K ($400K obligated). Current period of performance ends Mar 26, 2027. Last award drew 1 bidder. Place of performance: SYRACUSE NY. Related solicitation 75D301-24-Q-78323.
Recompete timing
PublicCurrent PoP ends Mar 26, 2027 (217 days remaining). Agencies typically plan 12–18 months ahead — at 7.1 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordSyracuse Research Corp — $468.1M obligated across 207 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75D30124F20029?
75D30124F20029 (TOX profile - TOX 10: perfluoroalkyls) is a Cdc Office Of Acquisition Services award with a potential value of $471K, currently held by Syracuse Research Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75D30124F20029?
Cdc Office Of Acquisition Services awarded 75D30124F20029 to Syracuse Research Corp (potential $471K).
Who is the incumbent on 75D30124F20029?
Syracuse Research Corp is the incumbent with $468.1M across 207 related awards in SCOUT’s public footprint. The current period of performance ends Mar 26, 2027.
When does Syracuse Research Corp’s 75D30124F20029 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 26, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
